These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 21527208

  • 1. Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France--The EDiTH VI study.
    St Guily JL, Jacquard AC, Prétet JL, Haesebaert J, Beby-Defaux A, Clavel C, Agius G, Birembaut P, Okaïs C, Léocmach Y, Soubeyrand B, Pradat P, Riethmuller D, Mougin C, Denis F.
    J Clin Virol; 2011 Jun; 51(2):100-4. PubMed ID: 21527208
    [Abstract] [Full Text] [Related]

  • 2. Human papillomavirus (HPV) in head and neck cancer.
    Syrjänen S.
    J Clin Virol; 2005 Mar; 32 Suppl 1():S59-66. PubMed ID: 15753013
    [Abstract] [Full Text] [Related]

  • 3. Low prevalence of human papillomavirus in oral cavity carcinomas.
    Machado J, Reis PP, Zhang T, Simpson C, Xu W, Perez-Ordonez B, Goldstein DP, Brown DH, Gilbert RW, Gullane PJ, Irish JC, Kamel-Reid S.
    Head Neck Oncol; 2010 Mar 12; 2():6. PubMed ID: 20226055
    [Abstract] [Full Text] [Related]

  • 4. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003.
    Ryerson AB, Peters ES, Coughlin SS, Chen VW, Gillison ML, Reichman ME, Wu X, Chaturvedi AK, Kawaoka K.
    Cancer; 2008 Nov 15; 113(10 Suppl):2901-9. PubMed ID: 18980273
    [Abstract] [Full Text] [Related]

  • 5. Head and neck squamous cell carcinoma: role of the human papillomavirus in tumour progression.
    De Petrini M, Rittà M, Schena M, Chiusa L, Campisi P, Giordano C, Landolfo V, Pecorari G, Landolfo S.
    New Microbiol; 2006 Jan 15; 29(1):25-33. PubMed ID: 16608122
    [Abstract] [Full Text] [Related]

  • 6. HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic.
    Tachezy R, Klozar J, Saláková M, Smith E, Turek L, Betka J, Kodet R, Hamsíková E.
    Oral Dis; 2005 May 15; 11(3):181-5. PubMed ID: 15888110
    [Abstract] [Full Text] [Related]

  • 7. [Prevalence of human papillomavirus infection in squamous cell carcinoma of the oral cavity, oropharynx and larynx].
    Villagómez-Ortíz VJ, Paz-Delgadillo DE, Marino-Martínez I, Ceseñas-Falcón LÁ, Sandoval-de la Fuente A, Reyes-Escobedo A.
    Cir Cir; 2016 May 15; 84(5):363-8. PubMed ID: 27032466
    [Abstract] [Full Text] [Related]

  • 8. Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity.
    Ha PK, Pai SI, Westra WH, Gillison ML, Tong BC, Sidransky D, Califano JA.
    Clin Cancer Res; 2002 May 15; 8(5):1203-9. PubMed ID: 12006539
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region.
    Parkin DM, Louie KS, Clifford G.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M1-16. PubMed ID: 18945410
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx.
    Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP, Turek LP, Haugen TH.
    Int J Cancer; 2003 Apr 10; 104(3):336-44. PubMed ID: 12569557
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. National prevalence of oral HPV infection and related risk factors in the U.S. adult population.
    Sanders AE, Slade GD, Patton LL.
    Oral Dis; 2012 Jul 10; 18(5):430-41. PubMed ID: 22251072
    [Abstract] [Full Text] [Related]

  • 15. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
    Hansson BG, Rosenquist K, Antonsson A, Wennerberg J, Schildt EB, Bladström A, Andersson G.
    Acta Otolaryngol; 2005 Dec 10; 125(12):1337-44. PubMed ID: 16303684
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oropharyngeal and laryngeal but not oral cancers are strongly associated with high-risk human papillomavirus in 172 Greek patients.
    Tsimplaki E, Argyri E, Sakellaridis A, Kyrodimos E, Xesfyngi D, Panotopoulou E.
    J Med Virol; 2017 Jan 10; 89(1):170-176. PubMed ID: 27335246
    [Abstract] [Full Text] [Related]

  • 19. Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions.
    Ribeiro KB, Levi JE, Pawlita M, Koifman S, Matos E, Eluf-Neto J, Wunsch-Filho V, Curado MP, Shangina O, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Daudt A, Menezes A, Bencko V, Mates D, Fernandez L, Fabianova E, Gheit T, Tommasino M, Boffetta P, Brennan P, Waterboer T.
    Int J Epidemiol; 2011 Apr 10; 40(2):489-502. PubMed ID: 21224273
    [Abstract] [Full Text] [Related]

  • 20. Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets.
    Hong AM, Grulich AE, Jones D, Lee CS, Garland SM, Dobbins TA, Clark JR, Harnett GB, Milross CG, O'Brien CJ, Rose BR.
    Vaccine; 2010 Apr 26; 28(19):3269-72. PubMed ID: 20226244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.